Loading
NASDAQHealthcareBiotechnology
Latest quote
$18.05
+$0.48 · +2.73%
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
Regular session
$18.05
+$0.48 · +2.73%
Regular session · ET · Market data may be delayed.
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
Day range
Current $18.05
52-week range
Current $18.05
Regular session · ET · Market data may be delayed.
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
Day range
Current $18.05
52-week range
Current $18.05
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
ARK Genomic Revolution ETFARKG14.69M0.70%1.56B USD0.75%$48.71-2.85%
iShares Russell 2000 ETFIWM4.51M0.01%78.56B USD0.19%$275.96-0.63%
iShares Russell 2000 Growth ETFIWO929.56K0.01%14.25B USD0.24%$351.92-0.97%
iShares Micro-Cap ETFIWC532.69K0.04%1.33B USD0.60%$181.65-0.93%
Vanguard Morningstar Total Stock Market ETFVTI472.18K0.00%2.3T USD0.03%$380.18-0.22%
Vanguard Extended Market ETFVXF175.7K0.00%95.4B USD0.05%$232.28-0.52%
iShares Russell 2500 ETFSMMD94.78K0.00%4.06B USD0.23%$85.495-0.41%
Global X - Russell 2000 ETFRSSL74.99K0.01%1.43B USD0.08%$107.96-0.67%ARK Genomic Revolution ETFARKGiShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOiShares Micro-Cap ETFIWCVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Russell 2500 ETFSMMDGlobal X - Russell 2000 ETFRSSLAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
